The Polynovo Ltd (ASX: PNV) share price has continued to decline despite the company reporting positive numbers in mid-January.
While the medical device company’s shares rose 2.33% to $1.315 yesterday, it hasn’t been so great in 2022. In fact, for the past 6 weeks (year to date), Polynovo shares have tumbled by almost 14%.
Below, we take a look at what is impacting the company’s share price of late.
Polynovo shares in top 10 open ASX short positions
The investor sentiment on the Polynovo share price has been negative due to the inconsistent performance of the business. This has ultimately attracted a large number of short sellers to the company’s registry.
Short-selling is a common trading strategy that aims to profit from the fall in the price of a security. The goal is for an investor to first borrow and sell the shares, and then buy them back at a lower price for a profit.
Last week, the Australian Securities & Investments Commission (ASIC) released its short position report revealing the level of short interest within companies.
As such, Polynovo remained in the top 10 list with 8.89% of its shares being heavily shorted by investors.
In comparison, the government body had a short interest of 3.65% in Polynovo last year on 4 February.
Given the large increase in short positions being taken up, it appears investors believe the company’s performance will be underwhelming.
Polynovo is scheduled to release its FY22 half-year results within the next two weeks.
Polynovo share price snapshot
Over the past 12 months, the Polynovo share price has continued its downward trend to post a 50% loss.
In comparison, the S&P/ASX 200 Healthcare (ASX: XHJ) sector has lost around 5% in the same time frame.
It’s worth noting that Polynovo shares hit a multi-year low of $1.185 late last month. This is a huge difference from when its shares were trading above the $4 mark in December 2020.
Polynovo presides a market capitalisation of about $870.12 million and has approximately 661.69 million shares outstanding.
The post The company’s last update was positive, so why are Polynovo (ASX:PNV) shares still among the most shorted on the ASX? appeared first on The Motley Fool Australia.
Should you invest $1,000 in Polynovo right now?
Before you consider Polynovo, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Polynovo wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- These are the 10 most shorted ASX shares
- These are the 10 most shorted ASX shares
- Polynovo (ASX:PNV) share price melts 31% in 2 weeks. What’s going on?
- These are the 10 most shorted ASX shares
- These were the worst performing ASX 200 shares last week
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/S62uxYb
Leave a Reply